Signaling pathways perturbing muscle mass.
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Purpose of review To discuss the mechanisms of muscle loss during cachexia. Recent findings Cachexia can be defined as a wasting of lean body mass that cannot be reversed nutrionally, indicating a dysregulation in the pathways maintaining body composition. In skeletal muscle, during cachexia, there is an upregulation of protein degradation. A search for transcriptional markers of muscle atrophy led to the discovery of the E3 ubiquitin ligases MuRF1 and MAFbx (also called Atrogin-1). These genes are upregulated in multiple models of atrophy and cachexia. They target particular protein substrates for degradation via the ubiquitin/proteasome pathway. The insulin-like growth factor-1 can block the transcriptional upregulation of MuRF1 and MAFbx via the phosphatidylinositol-3 kinase/Akt/Foxo pathway. MuRF1's substrates include several components of the sarcomeric thick filament, including myosin heavy chain. Thus, by blocking MuRF1, insulin-like growth factor-1 prevents the breakdown of the thick filament, particularly myosin heavy chain, which is asymmetrically lost in settings of cortisol-linked skeletal muscle atrophy. Insulin-like growth factor-1/phosphatidylinositol-3 kinase/Akt signaling also dominantly inhibits the effects of myostatin, which is a member of the transforming growth factor-[beta] family of proteins. Deletion or inhibition of myostatin causes a significant increase in skeletal muscle size. Recently, myostatin has been shown to act both by inhibiting gene activ…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These two systems are controlled by a transcriptional program that upregulates several crucial and rate-limiting enzymes (Glass, 2010; Jagoe and Goldberg, 2001).”
From Proteasome dysfunction induces muscle growth defects and protein aggregation (2014) · cites this paper as Glass, 2010
Citations
Cites
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
Self-citationSandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., et al. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1014 · Cited by 2,752
Self-citationDouble muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039
Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
Self-citationFoxO3 Controls Autophagy in Skeletal Muscle In Vivo
Mammucari, C., Milan, G., Romanello, V., Masiero, E., Rudolf, R., Del Piccolo, P., Burden, S. J., Di Lisi, R., Sandri, C., Zhao, J., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.001 · Cited by 1,953
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A., & Goldberg, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251541198 · Cited by 1,774
Rommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., Yancopoulos, G. D., & Glass, D. J. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1009 · Cited by 1,583
Self-citationA deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
Grobet, L., Royo Martin, L. J., Poncelet, D., Pirottin, D., Brouwers, B., Riquet, J., Schoeberlein, A., Dunner, S., Ménissier, F., Massabanda, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-71 · Cited by 1,556
Research works printed but not linked: 1
- Stitt, 2004, Mol Cell, 14, 395, 10.1016/S1097-2765(04)00211-4 · DOI · Paper page
Cited by
Items 201–300 of 359
Immunoproteasome in animal models of Duchenne muscular dystrophy
Chen, C.-N. J., Graber, T. G., Bratten, W. M., Ferrington, D. A., & Thompson, L. V. (2014) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-014-9385-x · Cited by 28
“Specifically, MuRF1 is a protein in the ubiquitin/proteasome pathway and has been found to be up-regulated in multiple models of muscle atrophy (Glass 2010).”
P38α-MAPK Signaling Inhibition Attenuates Soleus Atrophy during Early Stages of Muscle Unloading
Belova, S. P., Mochalova, E. P., Kostrominova, T. Y., Shenkman, B. S., & Nemirovskaya, T. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082756 · Cited by 23
“The role of Akt1 signaling as one of the key signaling pathways in skeletal muscle atrophy is well documented [31,32].”
BackgroundZhang, P., Li, W., Liu, H., Li, J., Wang, J., Li, Y., Chen, X., Yang, Z., & Fan, M. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-0023-4 · Cited by 23
“Studying of the molecular mechanisms underlying the HUinduced muscular atrophy has led to the understanding that in addition to being a structural connection between the cytoskeleton and the extracellular matrix, dystrophin plays a functional role in the loss of skeletal muscle mass [39, 40].”
BackgroundTaurine Rescues Cisplatin-Induced Muscle Atrophy in Vitro: A Morphological Study
Stacchiotti, A., Rovetta, F., Ferroni, M., Corsetti, G., Lavazza, A., Sberveglieri, G., & Aleo, M. F. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/840951 · Cited by 21
“Skeletal muscles are a plastic tissue that continuously renovates protein aggregates, exhausted organelles like mitochondria, and sarcoplasmic reticulum, to maintain an efficient metabolism [1].”
BackgroundSeiliez, I., Sabin, N., & Gabillard, J. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00828.2010 · Cited by 23
“In mammals, FoxO transcription factors are recognized to play a central role in the control of the expression of several genes coding for key mediators of skeletal muscle atrophy in response to atrophic and/or hypertrophic signaling (18).”
BackgroundKohsaka, H., Mimori, T., Kanda, T., Shimizu, J., Sunada, Y., Fujimoto, M., Kawaguchi, Y., Jinnin, M., Muro, Y., Ishihara, S., et al. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14604 · Cited by 21
“nals such as hormones, nutrients, cytokines and physical tension are involved in adjusting this balance (evidence level VI) [44].”
BackgroundDrosophila as a Model for Tumor-Induced Organ Wasting
Saavedra, P. H. V., & Perrimon, N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-23629-8_11 · Cited by 20
Glycogen Synthesis in Glycogenin 1–Deficient Patients: A Role for Glycogenin 2 in Muscle
Krag, T. O. B., Ruiz‐Ruiz, C., & Vissing, J. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00399 · Cited by 24
Mochalova, E. P., Belova, S. P., Kostrominova, T. Y., Shenkman, B. S., & Nemirovskaya, T. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134815 · Cited by 22
“Unloading results in skeletal muscle atrophy via activation of protein degradation and decrease of protein synthesis [16,17].”
BackgroundDe Gasperi, R., Graham, Z. A., Harlow, L. M., Bauman, W. A., Qin, W., & Cardozo, C. P. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166189 · Cited by 19
Yun, C., So, H.-K., Vuong, T. A., Na, M. W., Anh, S., Lee, H.-K., Kim, K. H., Kang, J., Bae, G., & Lee, S.-J. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.753643 · Cited by 22
Joshi, R., Kadeer, N., Sheriff, S., Friend, L. A., James, J. H., & Balasubramaniam, A. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.06.012 · Cited by 21
“tem is well established, and has been exploited to unravel the signal transduction pathways mediating the effects of various candidate drugs on muscle atrophy and hypertrophy (e.g., Dehoux et al., 2007; Glass, 2010; Sheriff et al., 2012).”
Influentialde Morais, H., Cassolla, P., Moreira, C. C. L., Bôas, S. K. F. V., Borba‐Murad, G. R., Bazotte, R. B., & de Souza, H. M. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1337-4 · Cited by 25
Influence of Amino Acids and Exercise on Muscle Protein Turnover, Particularly in Cancer Cachexia
Pradhan, R., Dieterich, W., Natarajan, A., Schwappacher, R., Reljic, D., Herrmann, H. J., Neurath, M. F., & Zopf, Y. (2024) · Cancers · doi:10.3390/cancers16101921 · Cited by 18
Saneyasu, T., Kimura, S., Inui, M., Yoshimoto, Y., Honda, K., & Kamisoyama, H. (2015) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2015.04.007 · Cited by 20
Functional classification of skeletal muscle networks. I. Normal physiology
Wang, Y., Winters, J. M., & Subramaniam, S. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01514.2011 · Cited by 19
“8 also shows key signaling proteins involved in muscle hypertrophy and atrophy linked through canonical pathways (36, 37) associated PI3K-mTOR path (hypertrophy) and TNF- -NF- B path (atrophy).”
BackgroundAversa, Z., Alamdari, N., & Hasselgren, P.-O. (2011) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2011.591365 · Cited by 18
Improvement of Duchenne muscular dystrophy phenotype following obestatin treatment
González‐Sánchez, J., Sánchez‐Temprano, A., Cid-Diaz, T., Pabst‐Fernández, R., Mosteiro, C. S., Gallego, R., Nogueiras, R., Casabiell, X. A., Butler-Browne, G. S., Mouly, V., et al. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12338 · Cited by 19
Kohsaka, H., Mimori, T., Kanda, T., Shimizu, J., Sunada, Y., Fujimoto, M., Kawaguchi, Y., Jinnin, M., Muro, Y., Ishihara, S., et al. (2018) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12223 · Cited by 17
Marzan, A. L., & Chitti, S. V. (2023) · Cells · doi:10.3390/cells12222598 · Cited by 18
“This stage is often followed by cachexia, where patients undergo weight loss of more than 5% within found to decrease, which subsequently reduces protein turnover in the muscle and per-turbs muscle mass [23].”
BackgroundHwee, D. T., Gomes, A. V., & Bodine, S. C. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00165.2011 · Cited by 17
“Although its role in striated muscle continues to be evaluated, MuRF1 appears to facilitate polyubiquitin chain formation via lysine 48 linkages on targeted substrates, leading to recognition and substrate degradation by the 26S proteasome complex (20).”
BackgroundGrundmann, S. M., Ress, K., Zimmermann, L., Höring, M., Liebisch, G., Most, E., Ringseis, R., & Eder, K. (2023) · Nutrients · doi:10.3390/nu15173734 · Cited by 16
“This results in the stimulation of downstream signaling molecules, such as mTOR and GSK-3 (glycogen synthase kinase 3), which promote the synthesis of proteins and inhibit their degradation, leading to muscle growth [59].”
BackgroundAcylated and unacylated ghrelin inhibit apoptosis in myoblasts cocultured with colon carcinoma cells
Zeng, X., Chen, S., Lin, Y., & Zhao, K. (2018) · Oncology Reports · doi:10.3892/or.2018.6213 · Cited by 17
Yang, J., Cao, R. Y., Li, Q. X., & Zhu, F. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1435-3_15 · Cited by 16
Chen, C., Jü, R., Zhu, L., Li, J., Chen, W., Zhang, D., Ye, C., & Guo, L. (2017) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-017-1345-8 · Cited by 19
“Another transcription factor NF-κB is required to upregulate the expressions of MuRF1 and atrogin1 (Glass 2010).”
BackgroundSkeletal Muscle microRNAs: Roles in Differentiation, Disease and Exercise
Sjögren, R. J. O., Niss, M. H. L. L., & Krook, A. (2017) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-319-72790-5_6 · Cited by 20
“The family of Forkhead Box O (FOXO) transcription factors, especially FOXO1 and FOXO3, are strong upstream regulators of both these genes during skeletal muscle atrophy (Glass 2010).”
BackgroundMotor performance of young dystrophic mdx mice treated with long‐circulating prednisolone liposomes
Weller, C., Zschüntzsch, J., Makosch, G., Metselaar, J. M., Klinker, F., Klinge, L., Liebetanz, D., & Schmidt, J. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.22825 · Cited by 16
“…the muscle F-box protein (MAFbx; alternate names: atrogin1, FBxO32) and the muscle ring finger protein 1 (MuRF1; alternate name: Trim63) are well-characterized markers of skeletal muscle atrophy (Glass, 2010; Foletta et al., 2011), which can be induced, e.g., by denervation or glucocorticosteroids.”
BackgroundYou, C., Lee, S.-J., Lee, J., Vuong, T. A., Lee, H., Jeong, S. Y., Alishir, A., Walker, A. S., Bae, G., Kim, K. H., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.84970 · Cited by 18
“Protein kinase B (AKT) signaling is another promyogenic signaling pathway critical for cell survival and differentiation of myoblasts triggered by the external signals like insulin-like growth factor [20-23].”
BackgroundPharmacology of doping agents—mechanisms promoting muscle hypertrophy
Kristina Parr, M., Pharmaceutical and Medicinal Chemistry, I. O. P., & Müller-Schöll, A. (2018) · AIMS Molecular Science · doi:10.3934/molsci.2018.2.131 · Cited by 15
Formicola, L., Pannérec, A., Correra, R. M., Gayraud-Morel, B., Ollitrault, D., Besson, V., Tajbakhsh, S., Lachey, J. L., Seehra, J. S., Marazzi, G., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00515 · Cited by 18
“The AcvR2B pathway has been a focus for the development of therapeutics for degenerative muscle diseases due to the recognition that these molecules antagonize myostatin and activin activity (Glass, 2010; Zhou and Lu, 2010; Ceco and McNally, 2013).”
BackgroundInfluentialPathological features of tissues and cell populations during cancer cachexia
Girolamo, D. D., & Tajbakhsh, S. (2022) · Cell Regeneration · doi:10.1186/s13619-022-00108-9 · Cited by 16
Jeong, J., Park, C.-H., Kim, I., Kim, Y.-H., Yoon, J.-M., Kim, K., & Kim, J. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1575-9 · Cited by 16
“FoxO is a known key molecule of muscle atrophy due to its role in the activation of protein degradation [13]: FoxO induces muscle atrophy by stimulating the E3 ubiquitin ligases Murf1 and Atrogin1 [26].”
BackgroundWu, X., Zhu, N., He, L., Xu, M., & Li, Y. (2024) · Antioxidants · doi:10.3390/antiox13020249 · Cited by 17
“Some studies found that the beneficial effects of IGF-1 mostly relied on the activation of the PI3K/Akt pathway, which promoted protein synthesis and blunted protein degradation [10–12].”
BackgroundLu, J., Wang, Q., Xie, L., Zhang, Q., & Sun, S. (2017) · Tobacco Induced Diseases · doi:10.1186/s12971-017-0148-5 · Cited by 20
Cornford, A. S., Barkan, A. L., Hinko, A., & Horowitz, J. F. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00320.2012 · Cited by 14
Vanderburg, C. R., & Clarke, M. S. F. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1538-x · Cited by 17
“, Type I to Type II shift), as well as alterations in satellite cell function are evident in a variety of disease states, including disuse atrophy [1], degenerative neuromuscular disease [2], obesity [3], sarcopenia [4], and cancer cachexia [5].”
BackgroundCho, C., Kim, Y., Park, S.-R., Kim, B. Y., Davis, C. S., Hwang, I., Brooks, S. V., Lee, J. H., & Kim, M. (2021) · Autophagy · doi:10.1080/15548627.2021.2016255 · Cited by 14
de Oliveira, C. H., Bernardes, R. D., Dias, K. M. M., Ribeiro, A. M., Rodrigueiro, R. J. B., Koo, B. K., Tak, J., Park, C., Calderano, A. A., & Albino, L. F. T. (2022) · Poultry Science · doi:10.1016/j.psj.2022.102270 · Cited by 15
“the major mechanism for protein degradation in vivo (Bodine et al., 2001; Glass, 2010).”
BackgroundRodrigues, C., Murata, G. M., Gerlinger‐Romero, F., Nachbar, R. T., Marzuca-Nassr, G. N., Gorjão, R., Vitzel, K. F., Hirabara, S. M., Pithon‐Curi, T. C., & Curi, R. (2023) · Nutrients · doi:10.3390/nu15224711 · Cited by 13
“…changes during hypertrophy are well documented in RET protocols, such as climbing [4,8,47–49]. protein synthesis and controls FOXO expression [18,48], MAFbx/atrogin-1 and MuRF-1, involved in protein degradation via the ubiquitin-proteasome system (UPS) that designates target proteins…”
BackgroundIyer, C. C., McGovern, V. L., Wise, D. O., Glass, D. J., & Burghes, A. H. M. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2014.02.007 · Cited by 14
Self-citationNakamura, K., Sasayama, A., Takahashi, T., & Yamaji, T. (2015) · Nutrition and Cancer · doi:10.1080/01635581.2015.1053495 · Cited by 13
Chaudhari, M., Zelko, I. N., Lorkiewicz, P., Hoetker, D., Nong, Y., Doelling, B., Brittian, K. R., Bhatnagar, A., Srivastava, S., & Baba, S. P. (2024) · Skeletal Muscle · doi:10.1186/s13395-024-00354-2 · Cited by 14
Lee, S.-J., Im, M., Park, S. K., Kim, J. Y., So, E. Y., Liang, O. D., Kang, J., & Bae, G. (2020) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x20500329 · Cited by 15
Changes in liver gluconeogenesis during the development of Walker‐256 tumour in rats
Moreira, C. C. L., Cassolla, P., Dornellas, A. P. S., de Morais, H., de Souza, C. O., Borba‐Murad, G. R., Bazotte, R. B., & de Souza, H. M. (2013) · International Journal of Experimental Pathology · doi:10.1111/iep.12002 · Cited by 12
“…pyruvate, Walker-256 tumour Cancer is a disease characterized by marked weight loss (cachexia) and by various metabolic abnormalities, caused by several factors produced by the tumour and the tissues of the tumour-bearing (Bennani-Baiti & Davis 2008; Tisdale 2008a,b, 2010a,b; Glass 2010).”
BackgroundMuscle protein kinetics in cancer cachexia
Johns, N., Stephens, N. A., & Preston, T. (2012) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e328359e6dd · Cited by 14
“Both molecules bind to activin type-2 receptor (ActRIIB), a receptor in muscle, to initiate a signalling cascade leading to increased expression of atrogin-1 and MuRF1 and subsequent degradation of myofibrillar proteins [25].”
BackgroundKim, R., Kim, H., Im, M., Park, S. K., Han, H. J., An, S., Kang, J., Lee, S.-J., & Bae, G. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18052367 · Cited by 16
“Muscle RING finger containing protein 1 (MuRF1) and Atrogin-1 are major muscle-specific E3 ubiquitin ligases associated with protein degradation in muscle cells [4,5] and are high-fidelity markers of the muscle atrophy phenotype [6].”
BackgroundCCN2 participates in overload-induced skeletal muscle hypertrophy
Petrosino, J. M., Longenecker, J. Z., Angell, C. D., Hinger, S. A., Martens, C. R., & Accornero, F. (2022) · Matrix Biology · doi:10.1016/j.matbio.2022.01.003 · Cited by 11
Aravena-Canales, D., Valenzuela‐Muñoz, V., Gallardo‐Escárate, C., Molina, A., & Valdés, J. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147586 · Cited by 12
“Prolonged cortisol release can result in negative consequences such as muscle breakdown, leading to the release of amino acids that can be utilized for energy production or the synthesis of new proteins in other tissues [15].”
BackgroundDevelopmental regulation of molecular signalling in fetal and neonatal diaphragm protein metabolism
Song, Y., & Pillow, J. J. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213494562 · Cited by 13
Skeletal Muscle, Function, and Muscle Fiber Types
Radak, Z. O. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-815137-2.00002-4 · Cited by 21
The Role of Skeletal Muscle Mitochondria in Colorectal Cancer Related Cachexia: Friends or Foes?
van de Haterd, B., Verboven, K., Vandenabeele, F., & Agten, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314833 · Cited by 11
Sausa, M., Fucarino, A., Paladino, L., Zummo, F. P., Fabbrizio, A., Felice, V. D., Rappa, F., Barone, R., Marino, A., & Macaluso, F. (2024) · Biomedicines · doi:10.3390/biomedicines12020382 · Cited by 12
A Novel Muscle Atrophy Mechanism: Myocyte Degeneration Due to Intracellular Iron Deprivation
Suh, D. K., Lee, W.-Y., Yeo, W. J., Kyung, B. S., Jung, K. W., Seo, H. K., Lee, Y.-S., & Suh, D. W. (2022) · Cells · doi:10.3390/cells11182853 · Cited by 13
Finlin, B. S., Varma, V., Nolen, G. T., Dubé, J. J., Starnes, C. P., Rasouli, N., Kern, P. A., & Peterson, C. A. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.04.013 · Cited by 13
“Co-culture with these macrophages results in a dramatic reduction of pAkt which would be predicted to induce both MAFbx and MuRF-1 since activation of Akt can dominantly repress both of these ubiquitin ligases [35].”
BackgroundInfluentialSaneyasu, T., Tsuchii, N., Nakano, Y., Kitashiro, A., Tsuchihashi, T., Shindo, H., Honda, K., & Kamisoyama, H. (2017) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2017.06.002 · Cited by 11
MiR-29ab1 Cluster Resists Muscle Atrophy Through Inhibiting MuRF1
Liu, C., Li, L., Ge, M., Gu, L., Zhang, K., Su, Y., Zhang, Y., Liu, C., Lan, M., Yu, Y., et al. (2021) · DNA and Cell Biology · doi:10.1089/dna.2021.0267 · Cited by 9
“Our work and that of others have shown that muscle atrophy is regulated by a transcription-dependent process that requires the expression of atrophy-related genes (Lecker et al. , 2004; Glass, 2010; Liu et al. , 2017).”
Jo, A. L., Ji Won, H. A. N., Ji In, A. N., Cho, K., & Jeoung, N. H. (2022) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.68.79 · Cited by 9
Warneke, K., Behm, D. G., Alizadeh, S., Hillebrecht, M., Konrad, A., & WIRTH, K. J. (2024) · Sports Medicine · doi:10.1007/s40279-024-02043-y · Cited by 19
“Assuming an increased net protein synthesis rate as important, it is notable that tension applied via stretching can cause a downregulation of anti-anabolic or catabolic mediators such as myostatin, MuRF1 or MAFbx via the insulin-like growth factor-1-induced inhibition of FOXO [112, 113, 166].”
BackgroundSamant, S. A., Pillai, V. B., & Gupta, M. P. (2020) · JCSM Rapid Communications · doi:10.1002/rco2.27 · Cited by 8
“diseases and manifests as an involuntary wasting of skeletal muscle with or without loss of adipose tissue.(1) Cachexia not only deteriorates the quality of life but also increases mortality in the cancer patients.”
BackgroundMeyer-Knees, J. W., Falkenthal, J., Geisel, D., Neumann, C., Hilfenhaus, G., Stephan, L. U., Schöning, W., Malinka, T., Pratschke, J., Stintzing, S., et al. (2024) · Cancers · doi:10.3390/cancers16061194 · Cited by 8
“The systemic inflammation has peripheral and central effects leading to the degradation of muscle mass, adipose tissue, and anorexia [17–19].”
BackgroundSassi, A. H., Monteil, J., Sauvant, P., & Atgié, C. (2012) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-012-0192-9 · Cited by 8
“dition to protein degradation [9].”
Making Muscles Grow by G Protein–Coupled Receptor Signaling
D, D. C. G. (2011) · Science Signaling · doi:10.1126/scisignal.2002670 · Cited by 8
Reining in nuclear factor-kappaB in skeletal muscle disorders
Shintaku, J., & Guttridge, D. C. (2013) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3283600e79 · Cited by 8
Zhang, X., Højlund, K., Luo, M., Meyer, C., Geetha, T., & Yi, Z. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.05.009 · Cited by 10
“In skeletal muscle, tyrosine phosphorylation of specific enzymes modulates insulin and growth factor signaling to glucose transport, glycogen synthesis, protein synthesis, and transcriptional activation [7,9,11,12].”
Basics of Skeletal Muscle Function and Normal Physiology
Brown, S., & Sewry, C. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800040-3.00002-9 · Cited by 10
Mechanism-Based Therapeutic Approaches to Cachexia
Penna, F., Bonelli, G., Baccino, F. M., & Costelli, P. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-410473-0.00011-8 · Cited by 9
“Such a strategy appears to work perfectly well in several experimental models of muscle wasting including denervation, amyotrophic lateral sclerosis, disuse (reviewed in Glass, 2010).”
BackgroundInfluentialPROTEIN CONSUMPTION AND RESISTANCE EXERCISE: MAXIMIZING ANABOLIC POTENTIAL
Phillips, S. M. (2013) · Cited by 13
Loss of function of phosphatidylserine synthase causes muscle atrophy in Drosophila
Kim, S., Heo, H., Kwon, S., Park, J. H., Lee, G., & Jeon, S. (2024) · Developmental Biology · doi:10.1016/j.ydbio.2024.03.006 · Cited by 7
Li, Y., Chen, Y., Liao, Y., Huang, T., Tang, Q., He, C., Liu, X., Chang, H., Li, H., Liu, Q., et al. (2024) · APOPTOSIS · doi:10.1007/s10495-024-01949-2 · Cited by 7
“The expression of E3 ubiquitin ligases and autophagy genes is significantly elevated in cachectic mice with muscle atrophy [14, 15], suggesting that these two pathways can be used as targets for the treatment of muscle atrophy [16].”
Orhan, C., Şahin, E., Er, B., Tuzcu, M., Lopes, A. P., Şahin, N., Juturu, V., & Şahin, K. (2021) · Animals · doi:10.3390/ani11030851 · Cited by 7
“During cachexia, MuRF1 and MAFbx are expressed explicitly in atrophying skeletal muscle and mediate muscle protein degradation [17].”
BackgroundAlterations in molecular muscle mass regulators after 8 days immobilizing Special Forces mission
Jespersen, J. G., Mikkelsen, U. R., Nedergaard, A., Thorlund, J. B., Schjerling, P., Suetta, C., Christensen, P. A., & Aagaard, P. (2014) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.12170 · Cited by 8
“…in the present study were highly trained in SSR techniques and prepared for such operations, we cannot rule out that a stress-related increase in the blood levels of cortisol may have occurred, which could activate protein breakdown and affect MuRF1 and atrogin1 transcription (Glass, 2010).”
BackgroundMainardi, L. G., Fernandes, R. C., & Pimentel, G. D. (2020) · Nutrition · doi:10.1016/j.nut.2020.110887 · Cited by 6
Ding, Z., Zhou, L., Zhou, Y. N., Jin, K., Wu, R., & Gui, Y. (2024) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.24-35 · Cited by 5
“(32) Overall, the loss of adipose tissue is preceded by muscle loss; however, higher weight and BMI loss are observed in the high SMI group, suggesting that the loss of muscle mass accounts for a significant proportion of weight loss.”
BackgroundEmbryonic Leucine Promotes Early Postnatal Growth via mTOR Signalling in Japanese Quails
Ndunguru, S. F., Reda, G. K., Csernus, B., Knop, R., Lugata, J. K., Szabó, C., Lendvai, Á. Z., & Czeglédi, L. (2024) · Animals · doi:10.3390/ani14172596 · Cited by 5
“Protein synthesis is interlinked with the protein kinase B/Akt pathway, with the Akt/mTOR pathway stimulating protein synthesis, and the Akt/FOXO1 pathway responsible for protein degradation [18,19].”
BackgroundExercise microdosing for skeletal muscle health applications to spaceflight
Voss, A. C., Chambers, T. L., Gries, K. J., Jemioło, B., Raue, U., Minchev, K., Begue, G., Lee, G. A., Trappe, T. A., & Trappe, S. W. (2024) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00491.2023 · Cited by 6
Ho, P. T. B., Park, E., Luong, Q. X. T., Hakim, M. D., Hoang, P. T., Thuỷ, V. T. B., Kawalin, K., Kang, H. G., Lee, T., & Lee, S. (2024) · Nutrients · doi:10.3390/nu16213671 · Cited by 5
Belova, S. P., Kalashnikova, E. P., Tyganov, S. A., Kostrominova, T. Y., Shenkman, B. S., & Nemirovskaya, T. L. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109291 · Cited by 6
Jun-mei, W., Tierney, L., Wilson, C., Phillips, V., Goldman, L., Mumaw, C. L., Muang, E., & Walker, C. L. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.01.023 · Cited by 5
Expression of Glucocorticoid Receptors in the Regenerating Human Skeletal Muscle
Filipović, D., Pirkmajer, S., Miš, K., Marš, T., & Grubič, Z. (2011) · Physiological Research · doi:10.33549/physiolres.932171 · Cited by 6
Gabriel, J. E., Alves, H., do Rosário, M. F., Secatto, A., Coutinho, L. L., & Macari, M. (2011) · Brazilian Journal of Biology · doi:10.1590/s1519-69842011000300030 · Cited by 5
Cinnamic acid-GPR109A pathway improves skeletal muscle hypertrophy and metabolism
Ma, Z., Li, P., Feng, X., Zhu, Y., Fan, L., Xu, G., Wang, L., Wang, S., Wu, R., Zhu, C., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156851 · Cited by 4
Yoon, J., Park, M., & Lee, H. (2026) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70425 · Cited by 4
Luo, X., Yang, X., Yang, Y., Li, H., Cui, H., & Cao, X. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1782435 · Cited by 5
“JAK/ STAT pathway or Akt/mTOR pathway might involve in the control of myoblast differentiation (Glass 2010, Moresi et al. 2019).”
BackgroundKushwaha, A. D., & Saraswat, D. (2022) · High Altitude Medicine & Biology · doi:10.1089/ham.2021.0127 · Cited by 4
“…highlighted that muscle proteolysis is mediated through E3 ligases (i.e., muscle ring finger-1 [MuRF-1] and muscle atrophy f-box protein [MAFbx]) (Glass, 2010), which are regulated by the fork head box transcription factors, mitogen-activated protein kinases, and nuclear factor kappa light chain…”
Granulocyte-colony stimulating factor enhances load-induced muscle hypertrophy in mice
Ohashi, M., Okubo, K., Mizuno, S., Yoda, M., Shirasawa, H., Chiba, K., Horiuchi, K., Matsumoto, M., & Nakamura, M. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.10.196 · Cited by 5
Liu, H., Li, X., Sun, L., Wang, H., Zhang, R., Yang, C., Li, L., Wang, J., He, H., & Krumm, C. S. (2014) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2013.12.003 · Cited by 4
“The IGF-1 signaling pathway has also been shown to interact with the TGF-β signaling pathway [19].”
BackgroundGand, L. V., Lanzuolo, C., Li, M., Rosti, V., Weber, N., Lu, D., Bär, C., Thum, T., Pich, A., Kraft, T., et al. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13776 · Cited by 3
“Furthermore, NF-κB down-regulates the master transcription factor MyoD and thereby suppresses skeletal muscle differentiation of myogenic progenitor cells [10, 11].”
Schaumburger, N., Pally, J., Moraru, I. I., Kositsawat, J., Kuchel, G. A., & Blinov, M. L. (2023) · Frontiers in Network Physiology · doi:10.3389/fnetp.2023.1079070 · Cited by 3
“In skeletal muscle, IGF-1 stimulates muscle fiber hypertrophy via increased protein synthesis (Semsarian et al., 1999) and decreased protein degradation (Glass, 2010).”
BackgroundStrategies to mitigate muscle mass loss in individuals with spinal cord injury
Horstman, A. M. H., Stolwijk-Swüste, J. M., van Loon, L. J. C., & de Groot, S. (2025) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2025.2503048 · Cited by 3
“Myostatin is a member of the TGF-β family of growth factors and has been shown to reduce the size of skeletal muscle (316,317).”
Metabolic and nutritional aspects of cancer
Krawczyk, J., Kraj, L., Ziarkiewicz, M., & Wiktor-Jędrzejczak, W. (2014) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/17322693.1118194 · Cited by 5
“Myostatin in turn stimulates the activity of the ubiquitin-proteasome system, which is responsible for degradation of ubiquitin-labelled proteins and negatively interferes with the mammalian target of rapamycin (mTOR) signalling pathway, mediating anabolic stimuli [2,18,26,31,42,43,44,45].”
BackgroundNF-kB Signaling in the Macroenvironment of Cancer Cachexia
Pryce, B. R., & Guttridge, D. C. (2022) · Springer eBooks · doi:10.1007/978-3-031-09518-4_7 · Cited by 3
Muscle biology after spinal cord injury: Recent advances and future challenges
Cardozo, C. P. (2018) · Acta Physiologica · doi:10.1111/apha.13073 · Cited by 3
“Muscle atrophy occurs when muscle protein breakdown (catabolism) exceeds protein synthesis (anabolism) and is commonly observed in a diverse array of conditions, including burns, starvation, infection, cancer cachexia, renal failure, immobilization or paralysis.(2) Considerable progress has been made towards elucidati…”
Backgroundde Oliveira, C. H., Dias, K. M. M., & Calderano, A. A. (2025) · World s Poultry Science Journal · doi:10.1080/00439339.2025.2507168 · Cited by 4
“For example, protein kinase B/Akt also regulates and inhibits the forkhead box protein O1 (FOXO1) transcription factor, which induces protein degradation (Glass 2010).”
Acides aminés à chaîne ramifiée et insulino-sensibilité : amis ou ennemis ?
Polakof, S. (2019) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2019.01.003 · Cited by 2
Enoki, Y., Kanezaki, Y., Takahata, I., Taguchi, K., & Matsumoto, K. (2024) · JCSM Communications · doi:10.1002/rco2.89 · Cited by 2
The Role of Specific Nutriments in Sarcopenia Associated With Chronic Diseases
Antoun, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-810422-4.00005-1 · Cited by 2
Carson, J. A., & Puppa, M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4493-0_5 · Cited by 2
Marzetti, E., Picca, A., Tummolo, A. M., & Calvani, R. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch99 · Cited by 2
Lee, J. I., Kim, D. W., Park, J. W., & Lee, D. H. (2025) · Journal of Reconstructive Microsurgery · doi:10.1055/a-2540-0786 · Cited by 1
“28 The mammalian target of rapamycin (mTOR) signaling pathway plays a crucial role in skeletal muscle maintenance by promoting protein synthesis, and can be attributed to muscle atrophy by downregulation of the mTOR signaling pathway.”
Protein Kinases in the Pathogenesis of Muscle Wasting
Penna, F., Costamagna, D., Camperi, A., Muscaritoli, M., Francesco, M., & Costelli, P. (2012) · InTech eBooks · doi:10.5772/38476 · Cited by 1
“Several situations characterized by muscle wasting, among which aging, type II diabetes, COPD, and inflammatory myopathies are associated with increased MAPK phosphorylation, p38 in particular (reviewed in Glass, 2010).”
BackgroundInfluential
Metadata
- Authors
- Glass, D. J.
- Corresponding author
- Glass, David J
- ORCID
- Glass, David J
- Venue
- Current Opinion in Clinical Nutrition and Metabolic Care
- Published
- 2010-05
- Volume
- 13
- Issue
- 3
- Pages
- 225-229
- ISSN
- 1363-1950 (ISSN-L)
- OpenAlex
- W2078192607
- Cited by
- 359
- References
- 56
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 17 · 2023: 9 · 2022: 17 · 2021: 13 · 2020: 15 · 2019: 14 · 2018: 25 · 2017: 20 · 2016: 13 · 2015: 30 · 2014: 28 · 2013: 45 · 2012: 55
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Clinical Nutrition & Metabolic Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- cachexia, skeletal muscle atrophy, muscle mass loss, MuRF1, atrogin-1, ubiquitin-proteasome system, protein degradation, insulin-like growth factor I, phosphatidylinositol 3-kinase/Akt signaling, FOXO, myostatin, TGF-beta, myosin heavy chain, cortisol, lean body mass
- MeSH terms
- Forkhead Box Protein O1, Cachexia, Gene Expression Regulation, Hydrocortisone, Muscle Proteins, Muscular Atrophy, Organ Size, Signal Transduction, Transforming Growth Factor beta, Muscle, Skeletal, Myosin Heavy Chains, Phosphatidylinositol 3-Kinases, Ubiquitin-Protein Ligases, Proto-Oncogene Proteins c-akt, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.